HCC/A2, the receptor binding domain of BoNT/A2, was previously shown to traffic to SV2C-enriched perinuclear vesicles (12, 41) Thus, βlac-TT(cis-loop) variants were not defective in intracellular trafficking. Here, SV2C is linked to hepatocellular carcinoma.